New pill aims to revive Insulin-Making cells in type 1 diabetes
Disease control
Terminated
This study tested an experimental drug called BMF-219 in adults with type 1 diabetes. The goal was to see if it could help the body produce more of its own insulin, reducing the need for injected insulin. The trial was stopped early, so results are limited.
Phase: PHASE2 • Sponsor: Biomea Fusion Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC